Replies to post #224914 on Biotech Values

[dewophile]

I'm ok with using the 100u as a pretext for needing more time to file the BLA, especially since the new timeline is consistent with other neurotoxin filings
On the call the milestone from mylan was characterized as significant if it materializes, there is money due this year from fosun if they get the filing done, and I think there could be top line readouts for some trials ahead of schedule - especially plantar fasciitis - based on when enrollment is scheduled to be completed. So I am going to stay the course